INTRODUCTION {#sec1-1}
============

Herbal remedies are very popular in the world on the ground that they are providing a valuable source of new antimicrobial agents.\[[@ref1][@ref2]\] It has been used for a long time in human history and 57% of the world population use medicinal herbs to treat their diseases.\[[@ref3]\] Medicinal plants were found to be more useful in comparison with synthetic drugs because of their safety, lower cost, and limited side effects.\[[@ref4]\] Treatment properties of herbal plants for AIDS, cancer, malaria, and chronic complaints have been reported.\[[@ref5][@ref6]\] Furthermore, certain essential oil had an acceptable antifungal effect in root canals.\[[@ref7]\]

*Candida* species are the pathogenic organism creating mucocutaneous and systemic disorders in humans, especially in immunocompromised patients such as transplant recipients and those with diabetes, xerostomia, malnutrition, malignancy, and poor oral hygiene.\[[@ref8][@ref9]\] Oral candidiasis can cause pain, dysphagia, loss of taste, burning, and food sensitivity\[[@ref10]\] and is the risk factor for systemic candidiasis in immunocompromised patients. Recent investigations revealed that invasive fungal infections occur in 36%--50% of the liver transplant recipients (LTRs), without antifungal prophylaxis with the mortality rate of 25%--90%.\[[@ref11][@ref12]\] *Candida (C) albicans* is the most prevalent fungus and *Candida glabrata* is the other common *Candida* species isolated from the oral cavity of infected patients.\[[@ref13]\] There are reports about the antifungal resistance in both *C. albicans* and *C. glabrata* species.\[[@ref13][@ref14]\] There is a need for new anti-*Candida* compounds with less toxicity and greater efficacy.

The aim of the present study was to compare the antifungal activity of Ziziphus (Z) spina Christi fruits (unripe and ripe) and Lawsonia (L) inermis leaf with two common antifungal drugs, nystatin and fluconazole, on *C. albicans* and *C. glabrata* species isolated from the oral cavity of LTRs.

SUBJECTS AND METHODS {#sec1-2}
====================

Preparation of extracts {#sec2-1}
-----------------------

*L. inermis* leaves and *Z. spina christi* fruits (unripe and ripe) were collected from South of Iran and identified by Medicinal and Natural Products Chemistry Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. The plant materials were dried at room temperature and ground into fine powders. The powders (300 grams) were macerated in 3 liters of ethanol (80%, v/v) at room temperature for 48 h. Extracts were filtered by filter funnels fitted with Whatman No 1 filter papers (Whatman, USA). The extracts were concentrated using an EYELA rotary evaporator (N-1000, Japan) set at 40°C--50°C and freeze-dried using the Edwards freeze dryer (Edwards High Vacuum International Crawley, Sussex, England).

Patients and sampling {#sec2-2}
---------------------

The study was undertaken on *Candida* species isolated from the LTRs enrolled in our previous study.\[[@ref15]\] Samples were provided from the palate, tongue, gums, and teeth by rubbing a sterile swab. The standard strain of *C. glabrata* ATCC2001 was used in parallel with the isolates.

Evaluation of minimum inhibitory concentration {#sec2-3}
----------------------------------------------

To evaluate the purity of 51 *C. albicans* and eight *C. glabrata* isolated from the patients, all species were cultured (twice) on potato dextrose agar (Oxoid Ltd; Basingstoke, Hampshire, England). The antifungal activity of fluconazole, nystatin, *L. inermis* leaves, and *Z. spina* chiristi fruit (ripe and unripe) extracts on *C. albicans* and *C. glabrata* (the most isolated yeasts) were evaluated based on the CLSI M27-A3 standard method in triplicate.\[[@ref16]\] Dilution equal to 0.5 McFarland was prepared for each *Candida* species. Dilution equal to 1 mg/ml was prepared for each extract and filtered with 0/2 μm filter paper (Sartorius, Germany). One hundred microliter RPMI 1640 broth (Sigma Chemical Co, Germany) buffered to PH 7.0 with MOPS buffer (Sigma, Germany) was poured into each well of 96-well plates. In the first column of wells, 100 μL of each extract added and mixed with RPMI, and serial dilution was prepared. Then, 100 μL of the 0.5 McFarland of standard and isolated *Candida* suspensions were added to each well except for negative controls. Totally, the concentrations between 25--0.05 μL, 64--0.125 μL, and 18--0.035 μL were used for each extract, fluconazole, and nystatin, respectively. In each series, 11^th^and 12^th^wells were considered as positive and negative wells, without extracts or antifungals and yeast suspension, respectively. The plates were incubated at 35°C for 24 h. The minimum inhibitory concentration (MIC) was defined as the lowest concentration of extract or antifungal with the 50% growth decreased, compared with the positive controls. The results are reported as the mean values recorded in three different experiments.

Evaluation of minimum fetal concentration {#sec2-4}
-----------------------------------------

To evaluate the MFC, 50 μl of each clear (without visual growth) homogenized well suspension was cultured onto the plates containing Sabouraud Dextrose Agar (Merck, Germany) in triplicate and incubated at 35°C for 48 h. The MFC was considered as the lowest concentration of drug that caused 99.9% inhibition of growth compared with positive control. In these investigations, each separated colony was equivalent to a viable cell (colony forming unit \[CFU\]). The mean viable *Candida* colony counts (CFU/mL) in three plates in different concentrations were compared with the mean viable fungal counts in the positive control (well without extract).

Ethical considerations {#sec2-5}
----------------------

This study was carried out in accordance with the Declaration of Helsinki and approved by the ethics committee of Shiraz University of Medical Sciences, Shiraz, Iran.

Statistics {#sec2-6}
----------

The results were analyzed using SPSS version 16 (Chicago, IL, USA) and the Mann--Whitney U-test. *P* \< 0.05 was considered statistically significant.

RESULTS {#sec1-3}
=======

The MIC50 and MIC90 value, mean, and standard deviation of each extract and antifungal agent (fluconazole and nystatin) on *C. albicans* and *C. glabrata* species were shown in Tables [1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}. Using Mann--Whitney test, we compared mean MIC values of the extracts and antifungal agents. The antifungal activity of unripe and ripe fruit extracts of *Z. spina christi* present a significant activity against the two *Candida* species (*P* \< 0.001 for *C. albicans* and *P* \< 0.04 for *C. glabrata*) and unripe fruits were more active than ripe ones. *L. inermis* leaf was similar to the unripe fruit of *Z. spina christi* in activity against *Candida* species (*P* = 0.375 for *C. albicans* and *P* = 1 for *C. glabrata*).
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Comparison between nystatin and extracts revealed that nystatin was the most active agent against all species. As for extracts and fluconazole, unripe fruits of *Z. spina* Christi and *L. inermis* leaves proved more active than fluconazole (*P* \< 0.001) in *C. glabrata*. Fluconazole was more active than ripe *Z. spina* Christi fruits with significant difference (*P* \< 0.001 for *C. albicans* and *P* \< 0.043 for *C. glabrata*). None of the extracts presented fungicidal activity on both *Candida* species.

DISCUSSION {#sec1-4}
==========

*L. inermis* or henna is an herb used in coloring hair, skin, and nails. Antibacterial and antifungal activities were reported for this plant in the literature.\[[@ref17][@ref18]\]*Z. spina*-christi, known as Christ\'s thorn Jujube or sidr, is an evergreen tree which grows in the warm-temperate climate including Africa, South Europe, Mediterranean, Australia, tropical America, South and East of Asia and Middle East.\[[@ref19][@ref20]\] They are very popular in Iranian traditional medicine.

*C. albicans* is the most frequent *Candida* species isolated from oral candidiasis and it was reportedly isolated from 53% of LTRs oral cavities as colonization in Nazhvani *et al*.\[[@ref15]\] This organism can act as a source of invasive and systemic *Candida* infection with a high mortality rate in the recipients.\[[@ref21]\] *C. glabrata* is a common fungal pathogen in the oral cavity, causing systemic and mucosal infections, and exhibiting natural resistance to azole antifungal agents.\[[@ref13]\] Our results showed similar anti-*Candida* growth inhibition effects of *L. inermis* leaf and unripe *Z. spina* Christi in comparison with fluconazole in *C. albicans*. These plants exhibited more growth inhibition effect in *C. glabrata* than fluconazole. In our study, MIC90 values for *L. inermis* and unripe *Z. spina* Christi in both *Candida* species were 0.1 μg/ml, but MIC90 values for fluconazole against *C. albicans* and *C. glabrata* were 0.5 μg/ml and 2 μg/ml, respectively. The antifungal activity of alcoholic extracts of *L. inermis* against *C. albicans* in Soliman *et al*. was reported 10 ± 1.3 μg/mL.\[[@ref22]\] For mold fungi, the MIC values of L. Inermis in Fusarium oxysporum and Aspergillus flavus were reported 12 μg/mL and 50 μg/mL, respectively.\[[@ref23]\] In another study, antimicrobial activity of *L. inermis*, ethanol leaf extracts against *C. albicans*, was reported to be similar to that of nystatin; however, petroleum ether extract was more active than it.\[[@ref24]\] The difference between the studies may be due to the type of the extract (petroleum ether, ethanolic, methanolic, and aqueous), the region the plants grow, and the fungal population studied (different species of yeasts or molds).

A recent study reported antioxidant, hypoglycemic, anti-inflammatory, and hypotensive properties for *Z. spina*-christi fruit.\[[@ref25]\] The antimicrobial effect of *Z. spina* Christi fruit, according to biological and chemical assays, was reported to be due to flavonoid subfractions (rutin, quercetin, myricetin, apigenin, quercetin-3-O-galactoside, luteolin, kaempferol and kaemferol-3-O-robinoside, apigenin-7-O-lucoside, quercitrin, quercetin, isovitexin, rutin and quercetin-3-O lucoside-7-O-arabinose rhamnoside).\[[@ref23]\] In Ads *et al*., ethyl acetate and alkaline ethyl acetate of ethanolic extract fractions of *Z. spina*-christi stem bark did not present any anti-*C. albicans* activity.\[[@ref26]\] In previous studies, the antifungal activity of unripe and ripe fruits separately was not investigated. We evaluated unripe and ripe fruit antifungal activities and observed a high anti-*Candida* activity for the unripe fruit.

There are a few studies which reported the MFC of these plants. In the present study, none of the plants exhibited fungicidal activity. The MFC of *Z. spina*-christi in *C. albicans* was reported \>1 μg/ml.\[[@ref23]\] It seems that such plants have not fungicidal activity in low extract concentrations.

CONCLUSION {#sec1-5}
==========

Given the resistance to antifungal agents and respective side effects, we need to find new agents as drug or mouthwash to prevent oral candidiasis. Developing a mouthwash with *Z. spina-christi* unripe fruit and *L. inermis* leaf extract for the treatment of *Candida* colonization and oral candidiasis in immunocompromised patients is suggested. Further studies in regard to pharmacokinetics and toxicities of these extracts are needed for their use in humans.
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